SNN Smith & Nephew plc
Healthcare$30.43-0.33%ClosedMarket Cap: $12.97B
As of 2026-05-26
Valuation
P/E (TTM)
13.04
PEG
0.11
P/B
2.52
P/S
2.08
EV/EBITDA
9.86
DCF Value
$29.31
FCF Yield
6.5%
Div Yield
2.6%
Margins & Returns
Gross Margin
68.0%
Operating Margin
16.3%
Net Margin
10.1%
ROE
11.8%
ROA
6.1%
ROIC
9.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $3.19B | 65.6% | $570.5M | $330.8M | $— | $0.29 |
| FY null | $6.18B | 68.0% | $1.01B | $626.5M | $— | $0.75 |
| Q2 null | $2.99B | 70.6% | $434.9M | $295.6M | $— | $0.46 |
| Q4 null | $2.98B | 69.5% | $329.0M | $198.0M | $— | $0.29 |
| FY null | $5.81B | 69.6% | $657.0M | $412.0M | $— | $0.75 |
| Q2 null | $2.83B | 69.8% | $328.0M | $214.0M | $— | $0.46 |
| Q4 null | $2.81B | 70.8% | $407.0M | $91.0M | $— | $0.29 |
| FY null | $5.55B | 68.8% | $425.0M | $263.0M | $— | $0.75 |
| Q2 null | $2.73B | 69.4% | $275.0M | $172.0M | $— | $0.46 |
| Q4 null | $2.62B | 71.4% | $423.0M | $46.0M | $— | $0.28 |
| FY null | $5.21B | 70.5% | $315.0M | $223.0M | $— | $0.73 |
| Q2 null | $2.60B | 70.3% | $242.0M | $177.0M | $— | $0.45 |